4.2 Article

Vitamin D Binding Protein Is Not Involved in Vitamin D Deficiency in Patients with Chronic Kidney Disease

Journal

BIOMED RESEARCH INTERNATIONAL
Volume 2015, Issue -, Pages -

Publisher

HINDAWI LTD
DOI: 10.1155/2015/492365

Keywords

-

Funding

  1. [PRVOUK-P25/LF1/2]
  2. [MH CZ-DRO VFN 64165]

Ask authors/readers for more resources

Objective. This study was designed to evaluate vitamin D status with separate determination of 25-OH D-2 and 25-OH D-3 and its relationship to vitamin D binding protein (VDBP) in patients with chronic kidney disease (CKD) and long-term haemodialysis patients (HD). Methods. 45 CKD patients, 103 HD patients, and 25 controls (C) were included. Plasma vitamin D concentrations were determined using chromatography and VDBP in serum and urine in CKD using enzyme immunoassay. Results. Plasma vitamin D levels were lower in CKD (30.16 +/- 16.74 ng/mL) and HD(18.85 +/- 15.85 ng/mL) versus C(48.72 +/- 18.35 ng/mL), P < 0.0001. 25-OH D-3 was the dominant form of vitamin D. Serum VDBP was higher in CKD (273.2 +/- 93.8 ug/mL) versus C (222 +/- 87.6 ug/mL) and HD (213.8 +/- 70.9 ug/mL), P = 0.0003. Vitamin D/VDBP ratio was the highest in C and the lowest in HD; however, there was no correlation between vitamin D and VDBP. Urinary concentration of VDBP in CKD (0.25 +/- 0.13 ug/mL) correlated with proteinuria (r = 0.43, P = 0.003). Conclusions. Plasma levels of vitamin D are decreased in CKD patients and especially in HD patients. 25-OH D-3 was the major form of vitamin D. Despite urinary losses of VDBP, CKD patients had higher serum VDBP concentrations, indicating compensatory enhanced production. Vitamin D binding protein is not involved in vitamin D deficiency.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Transplantation

The management of lupus nephritis as proposed by EULAR/ERA 2019 versus KDIGO 2021

Hans-Joachim Anders, Jerome Loutan, Annette Bruchfeld, Gema M. Fernandez-Juarez, Juergen Floege, Dimitrios Goumenos, Kultigin Turkmen, Cees van Kooten, Eleni Frangou, Kate Stevens, Andreas Kronbichler, Marten Segelmark, Vladimir Tesar

Summary: This article presents the updated guidelines on the management of lupus nephritis (LN) released by the European League for Rheumatism (EULAR) and other organizations. The article compares the differences between these guidelines and highlights their significance in LN management.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Article Urology & Nephrology

Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy

Jonathan Barratt, Richard Lafayette, Jens Kristensen, Andrew Stone, Daniel Cattran, Jurgen Floege, Vladimir Tesar, Hernan Trimarchi, Hong Zhang, Necmi Eren, Alexander Paliege, Brad H. Rovin

Summary: The clinical trial (NefIgArd) of a novel targeted-release formulation of oral budesonide (Nefecon) for the treatment of IgA nephropathy (IgAN) demonstrated significant improvements in proteinuria and glomerular filtration rate, with good tolerability.

KIDNEY INTERNATIONAL (2023)

Article Biochemistry & Molecular Biology

Unveiling IL-33/ST2 Pathway Unbalance in Cardiac Remodeling Due to Obesity in Zucker Fatty Rats

Clementina Sitzia, Elena Vianello, Elena Dozio, Marta Kalousova, Tomas Zima, Stefano Brizzola, Paola Roccabianca, Gabriella Tedeschi, John Lamont, Lorenza Tacchini, Massimiliano Marco Corsi-Romanelli

Summary: Obesity is associated with cardiovascular disease and mortality, and adipose-derived IL-33 plays a role in cardiac remodeling. The dysregulation of IL-33/ST2 signaling affects Epac proteins and myocardial gene expression, leading to pro-fibrotic effects. Ghrelin-induced IL-33 secretion counteracts fibrosis and influences transcription factor expression. The effect of IL-33 signaling depends on cell types' origin and the balancing of ST2 isoforms.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Serum and Urine Biomarkers Related to Kidney Fibrosis Predict Kidney Outcome in Czech Patients with IgA Nephropathy

Michaela Neprasova, Dita Maixnerova, Nadja Sparding, Federica Genovese, Morten Asser Karsdal, Helena Koprivova, Marek Kollar, Miloslav Suchanek, Zdenka Hruskova, Vladimir Tesar

Summary: By evaluating biomarkers related to kidney fibrosis, we can predict the outcome of patients with IgA nephropathy (IgAN). Clinical parameters and histological findings can be used to predict the kidney outcome. Biomarkers of collagen and laminin turnover in serum and urine can significantly differentiate IgAN patients with a worse prognosis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Urology & Nephrology

Risk Stratification to Predict Renal Survival in Anti-Glomerular Basement Membrane Disease

Lauren Floyd, Sebastian Bate, Abdul Hadi Kafagi, Nina Brown, Jennifer Scott, Mukunthan Srikantharajah, Marek Myslivecek, Graeme Reid, Faten Aqeel, Doubravka Frausova, Marek Kollar, Phuong Le Kieu, Bilal Khurshid, Charles D. Pusey, Ajay Dhaygude, Vladimir Tesar, Stephen McAdoo, Mark A. Little, Duvuru Geetha, Silke R. Brix

Summary: This study investigated clinical and histologic parameters in patients with anti-glomerular basement membrane (anti-GBM) disease to predict kidney outcomes and identify patients who may benefit from rescue immunosuppressive therapy. Stratifying patients based on the need for renal replacement therapy at diagnosis and renal histology improved prediction accuracy, emphasizing the importance of normal glomeruli.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2023)

Article Rheumatology

Predictors of hypogammaglobulinemia in ANCA-associated vasculitis after a rituximab-based induction: a multicentre study

Manuel Alfredo Podesta, Federica Mescia, Anna Ricchiuto, Rona Smith, Martina Tedesco, Matthias Arnaldo Cassia, Julia Holle, Renato Alberto Sinico, Annette Bruchfeld, Iva Gunnarsson, Sophie Ohlsson, Bo Baslund, Zdenka Hruskova, Vladimir Tesar, Gianmarco Sabiu, Maurizio Gallieni, Maria C. Cid, Augusto Vaglio, Lorraine Harper, Mario Cozzolino, Francesco Scolari, David Jayne, Federico Alberici

Summary: This study aims to assess factors associated with hypogammaglobulinemia in AAV patients treated with rituximab, and the results showed that hypogammaglobulinemia is common in AAV patients treated with rituximab, and lower IgG levels are associated with severe infections. Age and higher glucocorticoid doses increase the risk of hypogammaglobulinemia in these patients.

RHEUMATOLOGY (2023)

Article Multidisciplinary Sciences

Next-Generation Morphometry for pathomics-data mining in histopathology

David L. Hoelscher, Nassim Bouteldja, Mehdi Joodaki, Maria L. Russo, Yu-Chia Lan, Alireza Vafaei Sadr, Mingbo Cheng, Vladimir Tesar, Saskia V. Stillfried, Barbara M. Klinkhammer, Jonathan Barratt, Juergen Floege, Ian S. D. Roberts, Rosanna Coppo, Ivan G. Costa, Roman D. Buelow, Peter Boor

Summary: Pathology diagnostics still rely on tissue morphology assessment by trained experts. Here, the authors perform deep-learning-based segmentation followed by large-scale feature extraction of histological images, i.e., next-generation morphometry, to enable outcome-relevant and disease-specific pathomics analysis of non-tumor kidney pathology.

NATURE COMMUNICATIONS (2023)

Article Oncology

Low Frequency of Cancer-Predisposition Gene Mutations in Liver Transplant Candidates with Hepatocellular Carcinoma

Klara Horackova, Sona Frankova, Petra Zemankova, Petr Nehasil, Marta Cerna, Magdalena Neroldova, Barbora Otahalova, Jan Kral, Milena Hovhannisyan, Viktor Stranecky, Tomas Zima, Marketa Safarikova, Marta Kalousova, C. Z. E. C. A. N. C. A. CZECANCA Consortium, Jan Novotny, Jan Sperl, Marianna Borecka, Sandra Jelinkova, Michal Vocka, Marketa Janatova, Petra Kleiblova, Zdenek Kleibl, Milan Jirsa, Jana Soukupova

Summary: Hepatocellular carcinoma (HCC) mainly results from liver cirrhosis and its genetic predisposition is believed to be rare. In 334 HCC patients considered for liver transplantation, we found only 7 carriers of pathogenic variants in established cancer-predisposition genes. However, two MRN complex genes (NBN and RAD50) were significantly more frequent among patients. Therefore, HCC's genetic predisposition is rare, but germline testing could be considered in liver transplant recipients for tailored follow-up or targeted therapy.

CANCERS (2023)

Article Immunology

Biomarkers of fibrosis, kidney tissue injury and inflammation may predict severity and outcome of renal ANCA - associated vasculitis

Veronika Satrapova, Nadja Sparding, Federica Genovese, Morten Asser Karsdal, Lenka Bartonova, Doubravka Frausova, Eva Honsova, Marek Kollar, Miloslav Suchanek, Helena Koprivova, Romana Rysava, Vladimira Bednarova, Vladimir Tesar, Zdenka Hruskova

Summary: This study found that certain urinary biomarkers can reflect histopathological parameters in kidney biopsy and predict prognosis in patients with ANCA-associated vasculitis (AAV).

FRONTIERS IN IMMUNOLOGY (2023)

Article Pharmacology & Pharmacy

Intraperitoneally Administered Vancomycin in Patients with Peritoneal Dialysis-Associated Peritonitis: Population Pharmacokinetics and Dosing Implications

Jan Miroslav Hartinger, Danica Michalickova, Eliska Dvorackova, Karolina Hronova, Elke H. J. Krekels, Barbora Szonowska, Vladimira Bednarova, Hana Benakova, Gabriela Kroneislova, Jan Zavora, Vladimir Tesar, Ondrej Slanar

Summary: Peritonitis, a complication of peritoneal dialysis, can be treated with intraperitoneal administration of antibiotics. However, there are significant differences in dosing strategies for vancomycin, leading to potential underdosing in a large proportion of patients. Continuous dosing with a loading dose and dose adjustment based on plasma levels can improve intraperitoneal exposure and prevent toxicity.

PHARMACEUTICS (2023)

Article Cardiac & Cardiovascular Systems

Heart failure with preserved ejection fraction is the most frequent but commonly overlooked phenotype in patients on chronic hemodialysis

Jan Malik, Anna Valerianova, Satu Sinikka Pesickova, Kristyna Michalickova, Zuzana Hladinova, Zdenka Hruskova, Vladimira Bednarova, Katarina Rocinova, Monika Tothova, Marketa Kratochvilova, Lucie Kaiserova, Kristina Buryskova Salajova, Vaclav Lejsek, Martin Sevcik, Vladimir Tesar

Summary: This study aimed to analyze the prevalence of heart failure and its phenotypes in patients on chronic hemodialysis. The most common phenotype of heart failure in these patients was heart failure with preserved ejection fraction (HFpEF), followed by high-output heart failure. Patients with HFpEF were older and had increased hydration and higher filling pressures in both ventricles.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2023)

Editorial Material Urology & Nephrology

Targeting APRIL in the Treatment of IgA Nephropathy

Chee Kay Cheung, Jonathan Barratt, Kevin Carroll, Richard A. Lafayette, Adrian Liew, Yusuke Suzuki, Vladimir Tesar, Hernan Trimarchi, Muh Geot Wong, Hong Zhang, Vlado Perkovic, Dana V. Rizk

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2023)

Article Biochemistry & Molecular Biology

Unique Biomarkers of Collagen Type III Remodeling Reflect Different Information Regarding Pathological Kidney Tissue Alterations in Patients with IgA Nephropathy

Nadja Sparding, Michaela Neprasova, Dita Maixnerova, Federica Genovese, Morten Asser Karsdal, Marek Kollar, Helena Koprivova, Zdenka Hruskova, Vladimir Tesar

Summary: Kidney fibrosis, a characteristic of chronic kidney disease, can be assessed by measuring different biomarkers of collagen type III. In this study, three collagen type III biomarkers were measured in serum and urine samples of IgA nephropathy patients. The results showed that these biomarkers provided different information about fibrotic burden and had different correlations with the degree of fibrosis in kidney biopsies. Measuring different fragments of the same ECM protein in different matrices can provide valuable insights into pathological kidney tissue alterations in patients with IgA nephropathy.

BIOMOLECULES (2023)

Meeting Abstract Urology & Nephrology

LONG-TERM SPARSENTAN TREATMENT IN FSGS IN THE DUET OPEN-LABEL EXTENSION (OLE)

Howard Trachtman, Tarak Srivastava, Vladimir Tesar, Kirk N. Campbell, Michelle N. Rheault, Radko Komers, Edward Murphy, Andy Prasad, Loreto Gesualdo

AMERICAN JOURNAL OF KIDNEY DISEASES (2023)

Review Urology & Nephrology

An update on diagnosis and treatment of ANCA associated renal vasculitis

Kultigin Turkmen, Hakan Ozer, Vladimir Tesar

Summary: Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides are a group of diseases characterized by necrotizing inflammation of small vessels. Different subgroups of AAV, including GPA, MPA, and EGPA, are defined based on clinical features. Renal involvement is common in AAV, especially in MPA. The prognosis of untreated AAV is poor, but with appropriate immunosuppressive therapy, the 5-year renal survival rate can reach 70-75%. Challenges in the management of AAV include improving disease activity measures, determining optimal therapy duration, and exploring targeted therapies with fewer adverse effects.

INTERNATIONAL UROLOGY AND NEPHROLOGY (2023)

No Data Available